List of works by Giovanna Poce

1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.

scientific article published on 13 June 2009

1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.

scientific article published in June 2008

A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity

scientific article published on 26 April 2013

A novel antimycobacterial compound acts as an intracellular iron chelator

scientific article

Antimycobacterial Agents. Novel Diarylpyrrole Derivatives of BM212 Endowed with High Activity toward Mycobacterium tuberculosis and Low Cytotoxicity

scientific article published on 01 August 2006

Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class

scientific article published in February 2005

C-9 Alkenylidine bridged macrolides: WO2008061189

scientific article published on 01 June 2009

Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity

scientific article

Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach

scientific article published on 21 February 2011

Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors

scientific article published on 18 December 2013

Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.

scientific article published on January 2011

HPLC enantioseparation and absolute configuration of novel anti-inflammatory pyrrole derivatives

scientific article published on 01 June 2008

Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin

scientific article published on 19 September 2010

Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection

scientific article

Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme

scientific article published on 18 October 2012

Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography

scientific article

In vivo potent BM635 analogue with improved drug-like properties

scientific article published on 27 December 2017

MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212

scientific article

New oxazolidinone derivatives as antibacterial agents with improved activity

Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors

scientific article published on 11 April 2013

Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties

scientific article published on 31 October 2011

Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation

scientific article published in January 2010

One-Pot Conversions of Olefins to Cyclic Carbonates and Secondary Allylic and Homoallylic Amines to Cyclic Carbamates

scientific article published on 18 October 2010

Overcoming drug resistance in TB: an update

scientific article published on 20 November 2020

Pharmaceutical salt of BM635 with improved bioavailability

scientific article published on 8 December 2016

SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis

scientific article published on 31 August 2020

Stimuli-Responsive Tannin-FeIII Hybrid Microcapsules Demonstrated by the Active Release of an Anti-Tuberculosis Agent

scientific article published on 25 October 2018

Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors

scientific article published on 26 December 2014

Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents

scientific article published on 24 July 2008

The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and end

scientific article